Clinical Trial Update: Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study. [NA]

View source ↗

Summary

Open-label extension study in paediatric patients who completed the MEX-NM-301 trial for myotonic disorders; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Disorders

Drugs mentioned

• MEX-NM-301

Snippet

Sponsor: Lupin Ltd. | Conditions: Myotonic Disorders | NA | Status: ACTIVE_NOT_RECRUITING